![]() ![]() A day earlier, Sinovac turned out positive data from a 600-patient phase 2 study conducted in China, showing the shot was safe and triggered a neutralizing antibody response. ETĬhina's Sinovac launched a late-stage COVID-19 vaccine trial in Indonesia Tuesday with local drugmaker Bio Farma, aiming to enroll about 1,620 subjects to test its candidate, CoronaVac. ![]() The worldwide case count had climbed past 20.1 million Tuesday morning, with more than 737,000 reported deaths, according to Johns Hopkins University's COVID-19 dashboard.
0 Comments
Leave a Reply. |